In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, discusses her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.
March 27, 2018
Sponsored by
Thermo Fisher Scientific
Adding CNVs and Fusions to a Lung cfDNA Assay: Impact on Oncology Clinical Research
Genome Webinar
Join or Log in for Access
This content is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.
Sponsored by
